S&P 500   4,136.01 (-0.22%)
DOW   32,828.59 (+0.08%)
QQQ   320.24 (-0.47%)
AAPL   164.69 (-0.40%)
MSFT   279.78 (-1.11%)
META   171.15 (+2.42%)
GOOGL   117.25 (-0.19%)
AMZN   138.95 (-1.31%)
TSLA   880.83 (+1.89%)
NVDA   174.48 (-8.12%)
NIO   20.32 (+0.49%)
BABA   90.88 (-1.82%)
AMD   99.73 (-2.52%)
MU   61.50 (-1.54%)
T   18.10 (-1.36%)
CGC   3.20 (+18.52%)
GE   75.70 (+1.80%)
F   15.93 (+4.12%)
DIS   109.32 (+2.52%)
AMC   25.14 (+13.35%)
PYPL   96.19 (+0.91%)
PFE   49.14 (-0.26%)
NFLX   235.36 (+3.78%)
S&P 500   4,136.01 (-0.22%)
DOW   32,828.59 (+0.08%)
QQQ   320.24 (-0.47%)
AAPL   164.69 (-0.40%)
MSFT   279.78 (-1.11%)
META   171.15 (+2.42%)
GOOGL   117.25 (-0.19%)
AMZN   138.95 (-1.31%)
TSLA   880.83 (+1.89%)
NVDA   174.48 (-8.12%)
NIO   20.32 (+0.49%)
BABA   90.88 (-1.82%)
AMD   99.73 (-2.52%)
MU   61.50 (-1.54%)
T   18.10 (-1.36%)
CGC   3.20 (+18.52%)
GE   75.70 (+1.80%)
F   15.93 (+4.12%)
DIS   109.32 (+2.52%)
AMC   25.14 (+13.35%)
PYPL   96.19 (+0.91%)
PFE   49.14 (-0.26%)
NFLX   235.36 (+3.78%)
S&P 500   4,136.01 (-0.22%)
DOW   32,828.59 (+0.08%)
QQQ   320.24 (-0.47%)
AAPL   164.69 (-0.40%)
MSFT   279.78 (-1.11%)
META   171.15 (+2.42%)
GOOGL   117.25 (-0.19%)
AMZN   138.95 (-1.31%)
TSLA   880.83 (+1.89%)
NVDA   174.48 (-8.12%)
NIO   20.32 (+0.49%)
BABA   90.88 (-1.82%)
AMD   99.73 (-2.52%)
MU   61.50 (-1.54%)
T   18.10 (-1.36%)
CGC   3.20 (+18.52%)
GE   75.70 (+1.80%)
F   15.93 (+4.12%)
DIS   109.32 (+2.52%)
AMC   25.14 (+13.35%)
PYPL   96.19 (+0.91%)
PFE   49.14 (-0.26%)
NFLX   235.36 (+3.78%)
S&P 500   4,136.01 (-0.22%)
DOW   32,828.59 (+0.08%)
QQQ   320.24 (-0.47%)
AAPL   164.69 (-0.40%)
MSFT   279.78 (-1.11%)
META   171.15 (+2.42%)
GOOGL   117.25 (-0.19%)
AMZN   138.95 (-1.31%)
TSLA   880.83 (+1.89%)
NVDA   174.48 (-8.12%)
NIO   20.32 (+0.49%)
BABA   90.88 (-1.82%)
AMD   99.73 (-2.52%)
MU   61.50 (-1.54%)
T   18.10 (-1.36%)
CGC   3.20 (+18.52%)
GE   75.70 (+1.80%)
F   15.93 (+4.12%)
DIS   109.32 (+2.52%)
AMC   25.14 (+13.35%)
PYPL   96.19 (+0.91%)
PFE   49.14 (-0.26%)
NFLX   235.36 (+3.78%)
CVE:EMH

Emerald Health Therapeutics - EMH Stock Forecast, Price & News

C$0.26
-0.01 (-3.77%)
(As of 04/26/2021)
Add
Compare
Today's Range
C$0.25
C$0.27
50-Day Range
C$0.26
C$0.26
52-Week Range
C$0.15
C$0.53
Volume
384,329 shs
Average Volume
644,760 shs
Market Capitalization
C$52.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
EMH stock logo

About Emerald Health Therapeutics (CVE:EMH) Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EMH Stock News Headlines

Stocks in play: Emerald Health Therapeutics Inc
Avricore Health Inc
EMERALD HEALTH THER. (TBD.BE)
Emerald Health Therapeutics, Inc. (EMH.V)
Emerald Health Therapeutics Inc.
Stocks in play: Emerald Health Therapeutics
Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale
See More Headlines
Receive EMH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Emerald Health Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EMH Company Calendar

Last Earnings
7/08/2022
Today
8/08/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
161
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$13.02 million
Cash Flow
C$0.33 per share
Book Value
C$0.40 per share

Miscellaneous

Free Float
N/A
Market Cap
C$52.28 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Avtar S. Dhillon (Age 59)
    Exec. Chairman
    Comp: $485.05k
  • Mr. Riaz Bandali M.B.A. (Age 51)
    CEO & Pres
    Comp: $428.21k
  • Ms. Jenn Hepburn B.B.A.
    CFO & Company Sec.
  • Mr. Orville Bovenschen
    Sr. VP of Operations
  • Mr. Bernie Hertel
    VP of Fin. and Communications
  • Ms. Rebecca Wong
    Sr. VP of Quality & Regulatory Affairs













EMH Stock - Frequently Asked Questions

How has Emerald Health Therapeutics' stock price performed in 2022?

Emerald Health Therapeutics' stock was trading at C$0.26 at the start of the year. Since then, EMH shares have increased by 0.0% and is now trading at C$0.26.
View the best growth stocks for 2022 here
.

How were Emerald Health Therapeutics' earnings last quarter?

Emerald Health Therapeutics, Inc. (CVE:EMH) posted its quarterly earnings data on Friday, July, 8th. The company reported ($0.02) EPS for the quarter. The business earned $1.82 million during the quarter.

What other stocks do shareholders of Emerald Health Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Alibaba Group (BABA), Micron Technology (MU), CRISPR Therapeutics (CRSP), Charlotte's Web (CWBHF), OrganiGram (OGI), Emerald Health Therapeutics (EMHTF).

What is Emerald Health Therapeutics' stock symbol?

Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."

How do I buy shares of Emerald Health Therapeutics?

Shares of EMH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Emerald Health Therapeutics' stock price today?

One share of EMH stock can currently be purchased for approximately C$0.26.

How much money does Emerald Health Therapeutics make?

Emerald Health Therapeutics (CVE:EMH) has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year.

How many employees does Emerald Health Therapeutics have?

Emerald Health Therapeutics employs 161 workers across the globe.

How can I contact Emerald Health Therapeutics?

Emerald Health Therapeutics' mailing address is 4420 West Saanich Road, Rpo Royal Oak PO Box 24076, VICTORIA, BC V8Z 7E7, Canada. The official website for the company is www.emerald.care. The company can be reached via phone at +1-250-8189838.

This page (CVE:EMH) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.